10-Q Filing

YUBO INTERNATIONAL BIOTECH LTD CIK: 895464 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001193805-19-000624`
Period End Date	20190531
Filing Date	20190711
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	magaa-20190531.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 30 Income Statement 18 Cash Flow Statement 20 Stockholders Equity 10

Balance Sheet 30 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash	`Cash`	$6.00K	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	$4.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.00K	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.00K	USD	Point-in-time
Notes payable and accrued interest payable to a shareholder	`NotesAndLoansPayable`	$1.32M	USD	Point-in-time
Notes payable and accrued interest payable to a shareholder	`NotesAndLoansPayable`	$1.28M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$342.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$347.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$41.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$36.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.67M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.70M	USD	Point-in-time
Preferred stock, par value $.01 per share, 5,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $.01 per share, 5,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$27.29M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$27.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-28.99M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-28.95M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.56M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.52M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$6.00K	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$4.00K	USD	Point-in-time

Income Statement 18 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	1 Quarter
REVENUES	`Revenues`	-	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$21.00K	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$8.00K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-8.00K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-21.00K	USD	1 Quarter
OTHER EXPENSE - Interest expense	`InterestExpense`	$24.00K	USD	1 Quarter
OTHER EXPENSE - Interest expense	`InterestExpense`	$26.00K	USD	1 Quarter
NET LOSS BEFORE INCOME TAX	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-34.00K	USD	1 Quarter
NET LOSS BEFORE INCOME TAX	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-45.00K	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-45.00K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.18M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.18M	shares	1 Quarter
NET LOSS PER COMMON SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
NET LOSS PER COMMON SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter

Cash Flow Statement 20 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-45.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.00K	USD	1 Quarter
Accounts payable, accrued liabilities and all other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$26.00K	USD	1 Quarter
Accounts payable, accrued liabilities and all other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$31.00K	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-11.00K	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-8.00K	USD	1 Quarter
Proceeds received from notes payable to stockholder	`ProceedsFromRelatedPartyDebt`	$16.00K	USD	1 Quarter
Proceeds received from notes payable to stockholder	`ProceedsFromRelatedPartyDebt`	$10.00K	USD	1 Quarter
NET INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.00K	USD	1 Quarter
NET INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.00K	USD	1 Quarter
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.00K	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.00K	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.00K	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$4.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$2.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$6.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$7.00K	USD	Point-in-time

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Value, Balance, Beginning	`StockholdersEquity`	$-1.56M	USD	Point-in-time
Value, Balance, Beginning	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Value, Balance, Beginning	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Value, Balance, Beginning	`StockholdersEquity`	$-1.52M	USD	Point-in-time
Net Loss	`NetIncomeLoss`	$-45.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
Value, Balance, Ending	`StockholdersEquity`	$-1.56M	USD	Point-in-time
Value, Balance, Ending	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Value, Balance, Ending	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Value, Balance, Ending	`StockholdersEquity`	$-1.52M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.